AP
AMAG

Alydar Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Alydar Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$5.19M Sell
95,000
-447,903
-83% -$21.3M 2.81% 10
2014
Q4 		$23.1M Buy
542,903
+255,503
+89% +$9.23M 3.65% 4
2014
Q3 		$9.17M Buy
+287,400
New +$6.13M 0.99% 29

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Alydar Partners's AMAG Position: Q1 2015 in Review

Alydar Partners reduced its AMAG Pharmaceuticals (AMAG) stake by 83% in Q1 2015, selling an estimated $21.3M and leaving 95,000 shares worth $5.19M. The position accounts for 2.81% of the portfolio, ranked #10.

Alydar Partners first reported a position in AMAG in Q3 2014 and has held it in 3 quarters since. The position peaked at $23.1M in Q4 2014. 197 funds tracked by Wall St. Rank hold AMAG as of Q1 2015.

  • Alydar Partners held 95,000 shares of AMAG Pharmaceuticals worth $5.19M as of Q1 2015.
  • Alydar Partners sold 447,903 AMAG Pharmaceuticals shares in Q1 2015, an estimated $21.3M.
  • AMAG Pharmaceuticals made up 2.81% of Alydar Partners's portfolio in Q1 2015, its #10 holding.
  • Alydar Partners first reported a position in AMAG Pharmaceuticals in Q3 2014 and has held it in 3 quarters since.
  • Alydar Partners's AMAG Pharmaceuticals position peaked at $23.1M in Q4 2014.
  • 197 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2015.

Based on Alydar Partners's 13F filing for Q1 2015, filed 15 May 2015.